• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIOMED GMBH & CO. MEDIZINTECHNIK KG LIFESTENT STENT SYSTEM; VASCULAR STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIOMED GMBH & CO. MEDIZINTECHNIK KG LIFESTENT STENT SYSTEM; VASCULAR STENT Back to Search Results
Catalog Number EX061703C
Device Problem Fracture (1260)
Patient Problem Injury (2348)
Event Date 01/18/2020
Event Type  Injury  
Manufacturer Narrative
An image was provided to the manufacturer.The lot number for the device was provided.The device history records are currently under review.The device is not available for return.The investigation is currently underway.(expiry date: 06/2020).
 
Event Description
It was reported that approximately two weeks post implantation in the right superficial femoral artery via left femoral artery access, the stent was allegedly found fractured in an angiography.It was further reported that an additional procedure was required; a pta balloon and stent grafts of a different manufacturer were used to resolve the issue.The patient is reportedly stable.
 
Event Description
It was reported that approximately two weeks post implantation in the right superficial femoral artery via left femoral artery access, the stent was allegedly found fractured in an angiography.It was further reported that an additional procedure was required; a pta balloon and stent grafts of a different manufacturer were used to resolve the issue.The patient is reportedly stable.
 
Manufacturer Narrative
H10: manufacturing review: the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.Investigation summary: one image of the x-ray screen was provided for evaluation; the image demonstrated the placed stent inside the sfa in one plane; a strut structure evaluation was not possible due to poor resolution which led to an inconclusive evaluation result.A definite root cause could not be determined.Labeling review: in reviewing the relevant labeling for this product, it was found that the instructions for use (ifu) sufficiently address this potential risk.The ifu describe the stent deployment procedure by stating: 'confirm that the introducer sheath is secure and will not move during deployment (.) to ensure the most accurate placement, firmly hold the black system stability sheath throughout deployment (.) do not hold the silver stent delivery sheath at any time during deployment.Do not constrict the stent delivery sheath during stent deployment.(.) initiate stent deployment by rotating the thumbwheel in the direction of the arrows while holding the handle in a fixed position.(.) while maintaining a fixed handle position, rotate thumbwheel to obtain initial stent wall apposition of 1cm minimum.(.) with distal end of the stent apposing the vessel wall, deployment continues with the following method (.) while maintaining a fixed handle position, place your finger in front of the deployment slide and slide it from the distal to proximal end.' balloon pre and post dilation was addressed: 'predilation of the lesion should be performed using standard techniques.' and 'post stent expansion with a pta catheter is recommended.' the ifu further state: 'cases of stent fracture occurred in lesions that were moderate to severely calcified, proximal or distal to an area of stent overlap and in cases where stents experienced >10% elongation at deployment.Therefore, care should be taken when deploying the stent as manipulation of the delivery system may, in rare instances, lead to stent elongation and subsequent stent fracture.' h11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIFESTENT STENT SYSTEM
Type of Device
VASCULAR STENT
Manufacturer (Section D)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstrasse 6
karlsruhe 76227
GM  76227
MDR Report Key9913340
MDR Text Key187058250
Report Number9681442-2020-00074
Device Sequence Number1
Product Code NIP
UDI-Device Identifier04049519001500
UDI-Public(01)04049519001500
Combination Product (y/n)N
PMA/PMN Number
P070014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 05/15/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberEX061703C
Device Lot NumberANCT2422
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/03/2020
Initial Date FDA Received04/01/2020
Supplement Dates Manufacturer Received05/15/2020
Supplement Dates FDA Received05/15/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age65 YR
-
-